comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-29 20:52:43 - browse：88

Boston Globe

A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and pediatricians to scramble for alternatives just as allergy season is about to start.

In a move unusual for such a widely used drug, GlaxoSmithKline discontinued Flovent HFA, the brand name of its corticosteroid treatment fluticasone propionate, at the end of December. Critics, including Massachusetts Senator Elizabeth Warren, say the decision helps the company avoid new Medicaid penalties going into effect this year for medications with price increases that outpace inflation.

“It was all very confusing, and we were left scrambling, trying to find out what we could do,” said Simone Fung, whose 5-year-old son, David, endured worse asthma symptoms over the past two months as the Cambridge family navigated confusing insurance policies and shortages of alternative medications to find a replacement for Flovent.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： The strategy behind pharma's lawsuits over drug pricing reform

WSS

Elisabeth Bik tackles the widespread issue of research misconduct

Change Healthcare cyberattack shows risk of industry consolidation

Children’s Hospital revives plan for pedestrian bridge

The battle over the Brookhaven Landfill on Long Island

Disclosing genetic information: not as worrisome as once feared

Are embryos people? Reproductive medicine's future depends on the answer

Wikipedia

comprehensive

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

In areas with more Black doctors, Black people live longer

Continuity nursing helped my family in our darkest PICU moments

5 ways to address the shortage of health care workers

At least 13 dead in Texas as scorching temps continue

With FDA staff opposed to Sarepta therapy, top official intervened

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Why drug prescriptions should include diagnoses

Supreme Court strikes down use of affirmative action

STAT Madness 2024: Meet the contenders

Wikipedia

Do masks work? RCTs can't tell us

Pfizer is about to make a big push in cancer. Will investors listen?

The strategy behind pharma's lawsuits over drug pricing reform

Colonoscopy at 40? Study finds a possible benefit

Neuroscience renaissance leads to new crop of psychiatric drugs

Cloning humans is technically possible. It's curious no one has tried

focus

focus

explore

focus